To characterize aging as a factor responsible for structural changes, the retinae of 47 Wistar-derived albino rats and 50 pigmented rats of the Norway and BDE (Han) strains between the ages of 1 and 36 months were examined by light and electron microscopy and analyzed for changes in cell densities. In all 3 rats strains there was an overall decline in nuclear densities of outer layer nuclei by 38–50% and inner layer nuclei by 27–33% between the ages of 1 and 27 months. Over the same age range, the ganglion cell loss was comparable to the decline in the inner nuclear layer. Neuronal cell death occurred at all ages and was more pronounced in albino rats. Moreover, in albino rats, cones were more resistant than rods to destruction by age and ambient light. As age-related ultrastructural changes in the retinal pigment epithelium (RPE) (1) a substantial accumulation of lipo-fuscin; (2) an apparent thickening of the basement membrane; (3) greatly enlarged and pleomorphic basal infoldings, and (4) shorter apical microvilli were encountered. Besides mature stage IV melanosomes 27-month-old BDE (Han) and 36-month-old Norway rats also revealed stage III melanosomes. Tyrosinase activity in peripheral RPE cells could be demonstrated in Norway rats up to 12 months old and BDE (Han) rats up to 24 months old. Characteristics of RPE cells in old rats of these two pigmented strains were also melanolysosomes, melanophagolysosomes and melanolipofuscin granules. Age-related changes in retinal vessels were found in the superficial and deep capillary network and consisted of a 2- to 3-fold increase in thickness of the capillary basement membrane.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.